Home>APIs>

Fluticasone propionate

CAS number: 80474-14-2

Molecular formula: C25H31F3O5S

molecular weight: 500.57

Chemical structure:

Producers shown on SFDA

(Record date:15/10/2021)

Producer

Documents

GMP Valid till(based on SFDA)

Tianjin Tianyao Pharmaceutical Co., Ltd.
GMP
Valid till January 2020
:Lianyungang Runzhong Pharmaceutical Co., Ltd.
GMP
Valid till November 2021

Aurisco Pharmaceutical Co.,Ltd. 

GMP
Valid till July 2022

Hubei Hengan Fulin Pharmaceutical Co., Ltd.

GMP
Valid till October 2024


Producers shown on EP

(Quoted from EP website;record date:15/10/2021)

Substance
Certificate Holder
Certificate Number
Issue Date
Status
End date
Type
Fluticasone propionate
STERLING S.p.A. Solomeo Di Corciano IT
  R1-CEP 2005-268 - Rev 02
02/02/2016
Valid
/Chemical
Fluticasone propionate
CIPLA LIMITED Mumbai IN
  R1-CEP 2006-078 - Rev 02
29/02/2016
Valid
/
Chemical
Fluticasone propionate Anti-solvent Crystallized Code 2000134
STERLING S.p.A. Solomeo Di Corciano IT
  R0-CEP 2014-352 - Rev 03
01/04/2016
Expired
20/02/2020
Chemical
Fluticasone propionate Code 2000116
STERLING S.p.A. Solomeo Di Corciano IT
  R0-CEP 2013-014 - Rev 01
15/04/2016
Expired
17/05/2018
Chemical
Fluticasone propionate
SANOFI CHIMIE Gentilly FR
  R0-CEP 2013-158 - Rev 02
08/07/2016
Expired
17/04/2020
Chemical
Fluticasone propionate
AARTI INDUSTRIES LIMITED Mulund (W), Mumbai IN
  R1-CEP 2007-262 - Rev 02
26/10/2016
Valid
/
Chemical
Fluticasone propionate Micronised (Grade 21)
Farmabios SpA Gropello Cairoli IT
  R1-CEP 2008-117 - Rev 01
09/12/2016
Valid
/
Chemical
Fluticasone propionate
MYLAN LABORATORIES LIMITED Hyderabad IN
  R0-CEP 2014-134 - Rev 02
27/09/2017
Withdrawn by Holder
06/12/2019
Chemical
Fluticasone propionate Anti-solvent Crystallized Code 2000111
STERLING S.p.A. Solomeo Di Corciano IT
  R1-CEP 2012-345 - Rev 01
09/03/2018
Valid
/
Chemical
Fluticasone propionate Micronised, non-micronised
NEWCHEM S.p.A. Milano IT
  R1-CEP 2006-093 - Rev 02
30/05/2018
Valid
/
Chemical
Fluticasone propionate
Industriale Chimica S.R.L. Saronno IT
  R1-CEP 2012-024 - Rev 00
11/02/2019
Valid
/
Chemical
Fluticasone propionate
Hovione FarmaCiencia S.A. Loures PT
  R1-CEP 2005-160 - Rev 02
27/02/2019
Valid
/
Chemical
Fluticasone propionate
AURISCO PHARMACEUTICAL CO., LTD. Tiantai CN
  R1-CEP 2007-060 - Rev 04
24/05/2019
Valid
/
Chemical
Fluticasone propionate Process II, micronised, grades I and II
CIPLA LIMITED Mumbai IN
  R1-CEP 2012-001 - Rev 01
07/08/2019
Valid
/
Chemical
Fluticasone propionate Process III, micronised grade I, II, III
CIPLA LIMITED Mumbai IN
  R1-CEP 2012-056 - Rev 02
05/12/2019
Valid
/
Chemical
Fluticasone propionate
SUN PHARMACEUTICAL INDUSTRIES LIMITED Mumbai IN
  R1-CEP 2004-231 - Rev 04
12/12/2019
Valid
/
Chemical
Fluticasone propionate Modified Process II
CIPLA LIMITED Mumbai IN
  R0-CEP 2020-075 - Rev 00
17/08/2020
Valid
/
Chemical
Fluticasone propionate
Coral Drugs Private Limited New Delhi IN
  R1-CEP 2005-055 - Rev 03
25/09/2020
Valid
/
Chemical
Fluticasone propionate Micronised
GlaxoSmithKline Research & Development Limited London GB
  R0-CEP 2018-229 - Rev 01
07/12/2020
Valid
/
Chemical
Fluticasone propionate Process I
Hovione FarmaCiencia S.A. Loures PT
  R1-CEP 2011-103 - Rev 04
04/05/2021
Valid
/
Chemical
Fluticasone propionate
TEVA PHARMACEUTICAL INDUSTRIES LTD. Petach Tikva IL
  R1-CEP 2005-209 - Rev 02
10/06/2021
Valid
/
Chemical
Fluticasone propionate
WAVELENGTH ENTERPRISES LTD. Petah Tikva IL
  R1-CEP 2007-192 - Rev 07
18/06/2021
Valid
/
Chemical
Fluticasone propionate Non-micronised, micronised
SANOFI CHIMIE Gentilly FR
  R0-CEP 2018-040 - Rev 01
02/07/2021
Valid
/Chemical
Fluticasone propionate Micronised, non-micronised
FERMION OY Espoo FI
  R0-CEP 2020-008 - Rev 00
05/08/2021
Valid
/
Chemical
Fluticasone propionate
CURIA SPAIN S.A.U. Boecillo ES
  R1-CEP 2013-315 - Rev 01
25/08/2021
Valid
/
Chemical


Producer:Tianjin Tianyao Pharmaceutical Co., Ltd., a wholly-owned subsidiary of Tianjin Jinyao Group Co., Ltd., is the first API production unit in Tianjin that has all passed the national GMP certification. It is the largest scientific research, production and export base of steroid corticosteroids in Asia. The company mainly produces more than 40 varieties of corticosteroid raw materials, cardiovascular and cerebrovascular raw materials, analgesic raw materials and preparation drugs, of which many products have passed the certification of FDA and European Pharmacopoeia Committee, and become a qualified supplier of Pfizer and other large multinational companies. The company's leading product dexamethasone (corticosteroid drugs) series technology and product quality have reached the international advanced level. Taking advantage of low cost and service advantages, the company has occupied the Asian market of dexamethasone and opened the European and American markets; The company's annual production capacity of corticosteroid APIs has reached more than 200 tons.
Staff size:About 3000 persons

Registered capital:RMB 1 billion 101 million


Producer:Lianyungang Runzhong Pharmaceutical Co., Ltd., a wholly-owned subsidiary and API production base of Zhengda Tianqing Pharmaceutical Group, was established in 2010, covering an area of 206 mu. In 2012, it was recognized as a high-tech enterprise, mainly engaged in the R & D, production and sales of various chemical APIs.

At present, the company has 7 product production workshops, 4 pilot workshops for new products, 1 product development center, and 2 drug inspection centers, power workshops and warehouses. There are 52 products approved for listing in China, of which 16 are listed as high-tech products in Jiangsu Province, involving liver disease, tumor, cardiovascular, respiratory and other fields, with an annual production capacity of more than 100 tons.

With the continuous increase of product types and production scale, the economic benefits of the company have also increased year by year. In 2020, the sales revenue will reach 3.5 billion yuan, including 10 API products such as arotinib hydrochloride, magnesium isoglycyrrhizinate and Diammonium Glycyrrhizinate, forming a "product group with sales of more than 100 million". The company has passed FDA certification for "zero defect" twice, and 14 products passed GMP on-site inspection in 2020, indicating that the company's quality management is at a high level in the industry.

Staff size:1000-1999 persons

Registered capital:RMB 103 million 528 thousand and 805


Producer:Aurisco Pharmaceutical Co.,Ltd. was founded in 1998. The company focuses on the R & D, production and sales of characteristic complex APIs and preparations. It is an international pharmaceutical enterprise with continuous innovation. At present, the company has passed the GMP certification of SFDA, and many products have passed the official FDA certification of the United States, the official GMP certification of Germany, the official MHRA GMP certification of the United Kingdom and the official GMP certification of Mexico.

Staff size:About 1000 persons

Registered capital:RMB 401 million


Producer:Hubei Hengan Fulin Pharmaceutical Co., Ltd. was established in 2001,   Focusing on the development of drugs in the field of skin, the company has developed and launched a series of products covering the treatment of dermatitis, eczema, antifungal, antiviral and abnormal skin keratinization. It has become one of the professional preparation enterprises with many varieties, complete categories and high-end products at home and abroad.

The company has built various GMP production lines covering oral, external preparations, API and traditional Chinese medicine formula granules.

Staff size:About 300 persons

Registered capital:RMB 60 million


For supply and market information, please feel free to contact Mr. Paul, paulzhang@yinuopharmchem.com, WhatsApp: +86 18402846978